Clinical studies on esophageal squamous cell carcinoma (ESCC) reveals that patients with high TMEM16J expression exhibited significantly worst survival, poor prognosis and cell cycle inhibition by reduced expression of centrosome-related genes. Here, ANO9 is linked to esophageal squamous cell carcinoma.